Secondary metabolites in the post-genomic era

Kirsi-Marja Oksman-Caldentey, Suvi T. Häkkinen, Alain Goossens, Into Laakso, Tuulikki Seppänen-Laakso, Anna-Maria Nuutila, Dirk Inze

Research output: Chapter in Book/Report/Conference proceedingConference article in proceedingsScientificpeer-review


Many important pharmaceutical compounds are still isolated from plants. Due to their complex structures the chemical synthesis of these secondary metabolites is usually not applied. Plant cell cultures would offer an attractive alternative production system. However, the yields in cell cultures have only in few cases been commercially feasible. Futhermore, due to the lack of understanding of the biosynthetic pathways, genetic engineering has not had much success until now. It is expected that the application of genomics, proteomics and metabolomics tools will create a paradigm shift in our ability to engineer the often complex biosynthetic pathways of plant secondary metabolites. To illustrate the power of this approach, we present some data on the genome-wide transcript cDNA-AFLP profiling in combination with a GC-MS-SIM alkaloid analysis of methyl jasmonate elicited BY-2 tobacco cells used as a model system.
Original languageEnglish
Title of host publicationPlant Biotechnology 2002 and Beyond
EditorsIndra K. Vasil
ISBN (Electronic)978-94-017-2679-5
ISBN (Print)978-90-481-6220-8
Publication statusPublished - 2003
MoE publication typeNot Eligible
Event10th IAPTC&B Congress Plant Biotechnology 2002 and Beyond - Orlando, United States
Duration: 23 Jun 200228 Jun 2002
Conference number: 10


Conference10th IAPTC&B Congress Plant Biotechnology 2002 and Beyond
CountryUnited States


  • secondary metabolite
  • amplify fragment length polymorphism
  • methyl jasmonate
  • plant cell culture
  • plant secondary metabolite

Fingerprint Dive into the research topics of 'Secondary metabolites in the post-genomic era'. Together they form a unique fingerprint.

Cite this